摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(trifluoromethyl)-3-methylbenzo[b]thiophene-2-carboxylic acid | 752132-37-9

中文名称
——
中文别名
——
英文名称
5-(trifluoromethyl)-3-methylbenzo[b]thiophene-2-carboxylic acid
英文别名
3-methyl-5-trifluoromethylbenzo[b]thiophene-2-carboxylic acid;3-methyl-5-(trifluoromethyl)-1-benzothiophene-2-carboxylic acid;3-Methyl-5-trifluoromethyl-benzo[b]thiophene-2-carboxylic acid
5-(trifluoromethyl)-3-methylbenzo[b]thiophene-2-carboxylic acid化学式
CAS
752132-37-9
化学式
C11H7F3O2S
mdl
——
分子量
260.237
InChiKey
SYTUIESLSXFLLB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    377.7±37.0 °C(Predicted)
  • 密度:
    1.484±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    65.5
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS<br/>[FR] MODULATEURS DES RECEPTEURS ACTIVES PAR LES PROLIFERATEURS DE PEROXYSOMES
    申请人:LILLY CO ELI
    公开号:WO2005054176A1
    公开(公告)日:2005-06-16
    The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
    本发明涉及一种式(I)的化合物,或其药学上可接受的盐、溶剂合物、水合物或立体异构体,可用于治疗或预防由过氧化物酶体增殖物激活受体(PPAR)介导的疾病,如X综合征、2型糖尿病、高血糖、高脂血症、肥胖、凝血障碍、高血压、动脉粥样硬化以及其他与X综合征和心血管疾病相关的疾病。
  • Peroxisome proliferator activated receptor modulators
    申请人:Canada Jane Emily
    公开号:US20070082907A1
    公开(公告)日:2007-04-12
    The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
    本发明涉及一种式(I)的化合物,或其药学上可接受的盐、溶剂水合物或立体异构体,其可用于治疗或预防由过氧化物酶体增殖激活受体(PPAR)介导的疾病,例如X综合征、2型糖尿病、高血糖、高脂血症、肥胖症、凝血障碍、高血压、动脉硬化和其他与X综合征和心血管疾病相关的疾病。
  • Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease
    申请人:Harling David John
    公开号:US20070155805A1
    公开(公告)日:2007-07-05
    A compound of formula (I) and pharmaceutically acceptable salts and solvates and hydrolysable esters thereof.
    公式为(I)的化合物及其药学上可接受的盐、溶剂和可水解的酯。
  • METHOD FOR PROMOTING PLANT GROWTH
    申请人:SUMITOMO CHEMICAL COMPANY, LIMITED
    公开号:US20150289506A1
    公开(公告)日:2015-10-15
    The present invention provides a method for promoting plant growth, which comprises treating a plant with at least one compound selected from a group consisting of a compound represented by the following Formula (1): and an agriculturally acceptable salt thereof, provided that a method for promoting plant growth which comprises treating plants with a compound corresponding to any one of the following (1) to (5) and an agriculturally acceptable salt thereof is excluded: (1) 4-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, (2) 5-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, (3) 6-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, (4) 7-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, and (5) Benzo[b]thiophene-2-carboxylic acid.
    本发明提供了一种促进植物生长的方法,包括将植物处理至少一种化合物,所述化合物选自以下公式(1)表示的化合物组中的至少一种:以及其农业上可接受的盐,但是排除了使用与以下任一化合物(1)至(5)及其农业上可接受的盐相对应的化合物来促进植物生长的方法:(1)4-(三氟甲基)苯并[b]噻吩-2-羧酸,(2)5-(三氟甲基)苯并[b]噻吩-2-羧酸,(3)6-(三氟甲基)苯并[b]噻吩-2-羧酸,(4)7-(三氟甲基)苯并[b]噻吩-2-羧酸和(5)苯并[b]噻吩-2-羧酸。
  • Sulfonamide derivatives as ppar modulators
    申请人:Conner Eugene Scott
    公开号:US20060217433A1
    公开(公告)日:2006-09-28
    The present invention is directed to a compound of Formula (I): and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
    本发明涉及一种式(I)化合物:及其药学上可接受的盐、溶液剂、水合物或立体异构体,可用于治疗或预防由过氧化物酶体增殖物激活受体(PPAR)介导的疾病,如 X 综合征、II 型糖尿病、高血糖、高脂血症、肥胖、凝血功能障碍、高血压、动脉硬化以及其他与 X 综合征和心血管疾病相关的疾病。
查看更多

同类化合物